Advocacy intelligence hub — real-time data for patient organizations
National Cancer Institute (NCI) — PHASE2
National Cancer Institute (NCI) — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Adenocarcinoma of the liver and intrahepatic biliary tract news →
Eveline Boucher, MD
Centre Eugene Marquis
Nilofer S Azad, MD
JHU Sidney Kimmel Comprehensive Cancer Center LAO
📍 BALTIMORE, MD
Jonathan M Hernandez, M.D.
National Cancer Institute (NCI)
📍 Bethesda, Maryland
Felix Krenzien
Charite University, Berlin, Germany
View all Adenocarcinoma of the liver and intrahepatic biliary tract specialists →